Mithra Pharmaceuticals SA (OTCPK:MITPF)
$ 6.75 0 (0%) Market Cap: 15.66 Mil Enterprise Value: 215.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Q2 2022 Mithra Pharmaceuticals SA Earnings Call Transcript

Sep 23, 2022 / 07:00AM GMT
Release Date Price: $6.75
Operator

Hello, and welcome to the Mithra half year results 2022 call. My name is Rian, and I'll be your coordinator for today's event. (Operator Instructions)

I'll now hand you over to your host, Benoit Mathieu to begin today's conference. Thank you.

Benoit Mathieu
Mithra Pharmaceuticals SA - Group IR Manager

Good morning, ladies and gentlemen. My name is Benoit Mathieu, Group Investor Relations Manager at Mithra. Thank you all for dialing into this conference call and for being with us for the presentation of our half year results 2022. I am joined in the room by our CEO, Mr. Leon Van Rompay; Mr. Christophe Marechal, CFO; Mr. Graham Dixon, CEO -- CSO, sorry; and Mr. Jean-Manuel Fontaine, Chief Commercial Officer.

This webcast is recorded and will be accessible later today on Mithra's website. I would like to remind you that this webcast is covered by the disclaimer on Slide 2 of the presentation. The format of today's call will be as follows. A brief introduction will be given by Leon before handing over to Christophe for the explanation of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot